Skip to main content

Want a detailed portfolio tracker?

Cytokinetics (CYTK) P/E (2006 - 2026)

Cytokinetics (CYTK) P/E from Mar 31, 2006 to Jun 3, 2026. The TTM Cytokinetics (CYTK) P/E is -10.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cytokinetics (CYTK)

YearP/EChange
2026-10.33+6.25%
2025-9.73+9.11%
2024-8.91-41.06%
2023-15.12+4.45%
2022-14.48-10.11%
2021-16.11+56.21%
2020-10.31+105.42%
2019-5.02+55.18%
2018-3.23-33.97%
2017-4.90-95.75%
2016-115.36+965.64%
2015-10.83-42.12%
2014-18.70+282.14%
2013-4.89+193.55%
2012-1.67+19.36%
2011-1.40-48.70%
2010-2.72-141.05%
20096.63-363.56%
2008-2.52-45.38%
2007-4.61-29.22%
2006-6.51N/A

Comparison Cytokinetics (CYTK) P/E with competitors

Cytokinetics (CYTK) P/E is -10.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.99%
ENLVEnlivex Therapeutics Ltd0.15-101.45%
FGENFibroGen Inc0.24-102.32%
TRAWTraws Pharma Inc0.47-104.58%
FBIOFortress Biotech Inc0.71-106.83%
CHRSCoherus Biosciences Inc0.98-109.47%
ORMPOramed Pharmaceuticals Inc1.47-114.26%
AGENAgenus Inc2.05-119.82%
VIVSVivoSim Labs Inc2.54-124.54%
INVAInnoviva Inc3.19-130.86%
CRMDCorMedix Inc3.65-135.28%
ABEOAbeona Therapeutics Inc4.20-140.69%
VXRTVaxart Inc4.26-141.24%
CVACCureVac N.V.4.45-143.02%
SRPTSarepta Therapeutics Inc4.62-144.75%
GLPGGalapagos NV4.86-147.02%
RIGLRigel Pharmaceuticals4.92-147.61%
ZVRAZevra Therapeutics Inc4.97-148.14%
ABUSArbutus Biopharma Corp5.69-155.10%
CGENCompugen Ltd7.38-171.46%
AUPHAurinia Pharmaceuticals Inc9.25-189.53%
ACADAcadia Pharmaceuticals Inc9.59-192.79%
OMEROmeros Corporation9.88-195.65%
PLXProtalix BioTherapeutics Inc9.91-195.89%
SPROSpero Therapeutics Inc10.73-203.88%
ADMAAdma Biologics Inc11.33-209.65%
SVASinovac Biotech Ltd11.44-210.67%
TBPHTheravance Biopharma Inc11.78-213.97%
HRMYHarmony Biosciences Holdings Inc12.18-217.88%
TGTXTG Therapeutics Inc13.18-227.54%
INCYIncyte Corp13.38-229.50%
SABSSAB Biotherapeutics Inc14.06-236.04%
XOMAXOMA Corp14.95-244.63%
REGNRegeneron Pharmaceuticals Inc14.98-244.97%
PBYIPuma Biotechnology Inc15.05-245.65%
EXELExelixis Inc15.79-252.85%
NAGENiagen Bioscience Inc16.35-258.27%
CPRXCatalyst Pharmaceuticals Inc17.34-267.85%
MDXGMimedx Group Inc17.38-268.15%
ARGXArgen X SE23.07-323.27%
HALOHalozyme Therapeutics Inc23.20-324.52%
XOMAOXOMA Corp25.34-345.27%
VRTXVertex Pharmaceuticals Inc25.66-348.28%
XOMAPXOMA Corp25.67-348.42%
CTMXCytomX Therapeutics Inc25.70-348.69%
ASNDAscendis Pharma A/S26.35-355.04%
RPRXRoyalty Pharma plc - Class A27.50-366.09%
SLNOSoleno Therapeutics Inc29.02-380.79%
LGNDLigand Pharmaceuticals Inc - Class B30.19-392.13%
BMRNBiomarin Pharmaceutical Inc37.51-462.98%
APLSApellis Pharmaceuticals Inc39.02-477.63%
KRYSKrystal Biotech Inc39.70-484.17%
GMABGenmab40.20-489.07%
ONCBeiGene Ltd67.03-748.65%
TECHBio-Techne Corp68.59-763.83%
VCELVericel Corp80.63-880.29%
PHARPharming Group N.V.87.74-949.10%
ALNYAlnylam Pharmaceuticals Inc124.93-1309.04%
TLXTelix Pharmaceuticals Ltd139.89-1453.79%
CORTCorcept Therapeutics Inc158.39-1632.81%